Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon

Journal of Sports Medicine and Physical Fitness

Volumn 53, Issue 6, 2013, Pages 644-654

  Vinciguerra, G ^a   Belcaro, G ^a   Bonanni, E ^a   Cesarone, M R ^a   Rotondi, V ^a   Ledda, A ^a   Hosoi, M ^a   Dugall, M ^a   Cacchio, M ^a   Cornelli, U ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Dietary supplements; Fitness; Oxidative stress

Indexed keywords

FLAVONOID; IMMUNOLOGICAL ADJUVANT; PYCNOGENOLS;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXERCISE TEST; FEMALE; FITNESS; HUMAN; MALE; PHYSIOLOGY; REGISTER;

ADJUVANTS, IMMUNOLOGIC; ADULT; ATHLETIC PERFORMANCE; DIETARY SUPPLEMENTS; EXERCISE TEST; FEMALE; FLAVONOIDS; HUMANS; MALE; PHYSICAL FITNESS; REGISTRIES;

EID: 84894284028     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Morrow JR Jr, Tucker JS, Jackson AW, Martin SB, Greenleaf CA, Petrie TA. Meeting physical activity guidelines and health-related fitness in youth. Am J Prev Med 2013;44:439-44.
2. Jiménez-Pavón D, Sesé MA, Huybrechts I, Cuenca-García M, Palacios G, Ruiz JR et al. Dietary and lifestyle quality indices with/ without physical activity and markers of insulin resistance in European adolescents: the HELENA study. Br J Nutr 2013:1-7.
3. Sekulic D, Males B, Miletic D. Navy recruits: fitness measuring, validation, and norming. Mil Med 2006;171:749-52. (Pubitemid 44204885)
4. "President's Council on Physical Fitness and Sports Definitions for Health, Fitness, and Physical Activity". Archived from the original on August 25, 2012.
5. Kim BR, Han EY, Joo SJ, Kim SY, Yoon HM. Cardiovascular fitness as a predictor of functional recovery in subacute stroke patients. Disabil Rehabil 2013 [Epub ahead of print].
6. Mirandola D, Miccinesi G, Muraca MG, Sgambati E, Monaci M, Marini M. Evidence for adapted physical activity as an effective intervention for upper limb mobility and quality of life in breast cancer survivors. J Phys Act Health 2013 [Epub ahead of print].
7. Coombes JS, Law J, Lancashire B, Fassett RG. "Exercise is medicine": curbing the burden of chronic disease and physical inactivity. Asia Pac J Public Health 2013 [Epub ahead of print].
8. "US Department of Health and Human Services Presentation: Physical Activity Fundamental to Preventing Disease [Internet], [cited 2013 July 3]. Available at: http://aspe.hhs.gov/health/reports/physicalactivity/June 2002
9. "How much physical activity do adults need? 2008 Physical Activity 10. Shrestha M, Combest T, Fonda SJ, Alfonso A, Guerrero A. Effect of an accelerometer on body weight and fitness in overweight and obese active duty soldiers. Mil Med 2013;178:82-7.
10. Nikolaïdis PT. Physical fitness is inversely related with body mass index and body fat percentage in soccer players aged 16-18 years. Med Pregl 2012;65:470-5.
11. Heinrich KM, Spencer V, Fehl N, Poston WS. Mission essential fitness: comparison of functional circuit training to traditional Army physical training for active duty military. Mil Med 2012; 177:112530.
12. Wyss T, Von Vigier RO, Frey F, Mäder U. The swiss army physical fitness test battery predicts risk of overuse injuries among recruits. J Sports Med Phys Fitness 2012;52:513-21.
13. Sharp MA, Knapik JJ, Walker LA, Burrell L, Frykman PN, Darakjy SS et al. Physical fitness and body composition after a 9-month deployment to Afghanistan. Med Sci Sports Exerc 2008;40:1687-92.
14. Vanderburgh PM. Occupational relevance and body mass bias in milltary physical fitness tests. Med Sci Sports Exerc 2008;40:1538-45.
15. Thomas DQ, Lumpp SA, Schreiber JA, Keith JA. Physical fitness profile of Army ROTC cadets. J Strength Cond Res 2004;18:904-7. (Pubitemid 39627340)
16. Zivotič-Vanovič M, Dimitrijevié B, Zivanič S, Mijić R. Evaluation of physical fitness in military personnel using the 1600 meter running test]. Vojnosanit Pregl 1995;52:443-9
17. O'Connor JS, Bahrke MS, Tetu RG. 1988 Active Army Physical Fitness Survey. Mil Med 1990;155:579-85.
18. Knapik J. The Army Physical Fitness Test (APFT): a review of the literature. Mil Med 1989;154:326-9. (Pubitemid 19152061)
19. Guidelines for Americans [Internet]. Available at: http://www.cdc. gov/physicalactivity/everyone/guidelines/adults.html
20. Kawano H, Iemitsu M, Gando Y, Ishijima T, Asaka M, Aoyama T et al. Habitual rowing exercise is associated with high physical fitness without affecting arterial stiffness in older men. J Sports Sci 2012;30:241-6.
21. Traustadóttir T, Davies SS, Su Y, Choi L, Brown-Borg HM, Roberts LJ 2nd et al. Oxidative stress in older adults: effects of physical fitness. Age (Dordr) 2012;34:969-82.
22. Silva LA, Tromm CB, Da Rosa G, Bom K, Luciano TF, Tuon T et al. Creatine supplementation does not decrease oxidative stress and inflammation in skeletal muscle after eccentric exercise. J Sports Sci 2013 [Epub ahead of print].
23. Jendzjowsky NG, Delorey DS. Acute superoxide scavenging reduces sympathetic vasoconstrictor responsiveness in short-term exercise trained rats. J Appl Physiol 2013 [Epub ahead of print],
24. Ga̧siorowski A, Dutkiewicz J. Weight training and appropriate nutrient supplementation as an alternative method to pharmacological treatment in rehabilitation of post-myocardial infarction patients. Ann Agrie Environ Med 2012; 19:333-8.
25. Bentley DJ, Dank S, Coupland R, Midgley A, Spence I. Acute antioxidant supplementation improves endurance performance in trained athletes. Res Sports Med 2012;20:1-12.
26. Belcaro G, Cesarone MR, Dugall M, Hosoi M, Ippolito E, Bavera P et al. Investigation of Pycnogenol® in combination with coenzymeQlO in heart failure patients (NYHA II/III). Panminerva Med 2010;52(2 Suppl l):21-5.
27. Vinciguerra G, Belcaro G, Cesarone MR, Rohdewald P, Stuard S, Ricci A et al. Cramps and muscular pain: prevention with pycnogencl in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy. Angiology 2006;57:331-9. (Pubitemid 44438553)
28. Belcaro G, Cesarone MR, Rohdewald P, Ricci A, Ippolito E, Dugall M et al. Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol. Clin Appl Thromb Hemost 2004;10:373-7. (Pubitemid 39391298)
29. Tamopolsky MA, Safdar A. The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults. Appl Physiol Nutr Metab 2008;33:213-27.
30. Galán AI, Palacios E, Ruiz F, Diez A, Arji M, Almar M et al. Exercise, oxidative stress and risk of cardiovascular disease in the elderly. Protective role of antioxidant functional foods. Biofactors 2006;27:167-83. (Pubitemid 44434941)
31. McAnulty SR, McAnulty LS, Nieman DC, Morrow JD, Shooter LA, Holmes S et al. Effect of alpha-tocopherol supplementation on plasma homocysteine and oxidative stress in highly trained athletes before and after exhaustive exercise. J Nutr Biochem 2005; 16:530-7. (Pubitemid 41188033)
32. Belcaro G, Comelli U, Dugall M, Luzzi R, Hosoi M, Ledda A et al. Panel 2013 supplements and greendrugs studies; new rules 2013. London and Annecy Panel; 2013.
33. Belcaro G, Nicolaides AN. A new role for natural drugs in cardiovascular medicine. Angiology 2001 ;52(Suppl 2):S 1.
34. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G et al. Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Phytomedicine 2010;17:835-9.
35. Cesarone MR, Belcaro G, Rohdewald P, Pellegrini L, Ledda A, Vinciguerra G et al. Rapid relief of signs/symptoms in chronic venous microangiopathy with Pycnogenol: a prospective, controlled study. Angiology 2006;57:569-76. Erratum in: Angiology 2008;59:385. (Pubitemid 44564312)
36. Belcaro G, Cesarone MR, Ricci A, Comelli U, Rohdewald P, Ledda A et al. Control of edema in hypertensive subjects treated with calcium antagonist (nifedipine) or angiotensin-converting enzyme inhibitors with Pycnogenol. Clin Appl Thromb Hemost 2006; 12:440.
37. Cesarone MR, Belcaro G, Nicolaides AN, Ricci A, Geroulakos G, Ippolito E et al. Prevention of venous thrombosis in long-haul flights with Flite Tabs: the LONFLIT-FLITE randomized, controlled trial. Angiology 2003;54:531-9. (Pubitemid 37179936)
38. Belcaro G, Cesarone MR, Errichi BM, Ledda A, Di Renzo A, Stuard S et al. Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol. Angiology 2005;56: 699-705. (Pubitemid 41790978)
39. Errichi BM, Belcaro G, Hosoi M, Cesarone MR, Dugall M, Feragalli B et al. Prevention of post thrombotic syndrome with Pycnogencl® in a twelve month study. Panminerva Med 2011;53(3 Suppl 1):21-7.
40. Nuzum DS, Gebru TT, Kouzi SA. Pycnogenol for chronic venous insufficiency. Am J Health Syst Pharm 2011;68:1589-90, 1599-601.
41. Comelli U, Belcaro G, Ledda A, Feragalli B. Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. Panminerva Med 2011;53(3 Suppl 1):99-103.
42. Comelli U, Belcaro G, Ledda A, Feragalli B. Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. Panminerva Med 2011;53(3 Suppl 1):958.
43. Incandela L et al. A simple test to monitor oxidative stress. Int Angiol 1999;18:127-30. (Pubitemid 29306588)
44. Comelli U. Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants. Neurodegener Dis 2010;7:193-202.
45. Campise M, Bamonti F, Novembrino C, Ippolito S, Tarantino A, Comelli U et al. Oxidative stress in kidney transplant patients. Transplantation 2003;76:1474-8. (Pubitemid 37467697)
46. Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Griffin M, Cacchio M et al. Oxygen-free radical decrease in hypertensive patients treated with lercanidipine. Int Angiol 2001;20:136-40. (Pubitemid 32982594)
47. Comelli U. Antioxidant use in nutraceuticals. Clin Dermatol 2009;27:175-94.
48. Freedman A. Statistical models, theory and practice. Cambridge: Cambridge University Press; 2009.
49. Bottari A, Belcaro G, Ledda A, Cesarone MR, Vinciguerra G, Di Renzo A et al. Kidney function in metabolic syndrome may be improved with Pycnogenol®. Panminerva Med 2010;52(2 Suppl. l):27-32.
50. Cesarone MR, Belcaro G, Stuart S. Kidney flow and function in hypertension: Protective effects of Pycnogenol in hypertensive subjects - A controlled study. J. of cardiovascular pharmacology & Therapeutics 2010;15:41-46.